Protein Description

Gene Symbol SPHK1
Entrez ID 8877
Uniprot ID Q9NYA1
Description sphingosine kinase 1
Chromosomal Location chr17: 76,376,584-76,387,860
Ontology GO ID GO Term Definition Evidence

BP

GO:0001568

blood vessel development

The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.

IEA

BP

GO:0003376

sphingosine-1-phosphate signaling pathway

A series of molecular signals initiated by the sphingolipid sphingosine-1-phosphate (S1P) binding to a receptor on the surface of the cell, and which proceeds with the activated receptor transmitting the signal by promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The pathway ends with regulation of a downstream cellular process, e.g. transcription.

IEA

BP

GO:0006457

protein folding

The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure.

TAS

BP

GO:0006670

sphingosine metabolic process

The chemical reactions and pathways involving sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.

IDA

BP

GO:0006954

inflammatory response

The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.

IEA

BP

GO:0007165

signal transduction

The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

TAS

BP

GO:0007420

brain development

The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).

IEA

BP

GO:0010800

positive regulation of peptidyl-threonine phosphorylation

Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.

IMP

BP

GO:0010803

regulation of tumor necrosis factor-mediated signaling pathway

Any process that modulates the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor.

IDA

BP

GO:0019722

calcium-mediated signaling

Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions.

IDA

BP

GO:0030148

sphingolipid biosynthetic process

The chemical reactions and pathways resulting in the formation of sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).

TAS

BP

GO:0030307

positive regulation of cell growth

Any process that activates or increases the frequency, rate, extent or direction of cell growth.

IDA

BP

GO:0030335

positive regulation of cell migration

Any process that activates or increases the frequency, rate or extent of cell migration.

IDA

BP

GO:0031398

positive regulation of protein ubiquitination

Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.

IDA

BP

GO:0032651

regulation of interleukin-1 beta production

Any process that modulates the frequency, rate, or extent of interleukin-1 beta production.

IEA

BP

GO:0035556

intracellular signal transduction

The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.

TAS

BP

GO:0042346

positive regulation of NF-kappaB import into nucleus

Any process that activates or increases the frequency, rate or extent of transfer of NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters, from the cytoplasm into the nucleus, across the nuclear membrane.

IMP

BP

GO:0043066

negative regulation of apoptotic process

Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.

IDA|TAS

BP

GO:0045766

positive regulation of angiogenesis

Any process that activates or increases angiogenesis.

IDA

BP

GO:0045931

positive regulation of mitotic cell cycle

Any process that activates or increases the rate or extent of progression through the mitotic cell cycle.

IDA

BP

GO:0045987

positive regulation of smooth muscle contraction

Any process that activates or increases the frequency, rate or extent of smooth muscle contraction.

IDA

BP

GO:0046512

sphingosine biosynthetic process

The chemical reactions and pathways resulting in the formation of sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.

IGI|IMP

BP

GO:0046521

sphingoid catabolic process

The chemical reactions and pathways resulting in the breakdown of sphingoids, any of a class of compounds comprising sphinganine and its homologues and stereoisomers, and derivatives of these compounds.

NAS

BP

GO:0046834

lipid phosphorylation

The process of introducing one or more phosphate groups into a lipid, any member of a group of substances soluble in lipid solvents but only sparingly soluble in aqueous solvents.

IEA

BP

GO:0048146

positive regulation of fibroblast proliferation

Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.

IDA

BP

GO:0051092

positive regulation of NF-kappaB transcription factor activity

Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.

IMP

CC

GO:0005634

nucleus

A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

IEA

CC

GO:0005737

cytoplasm

All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

IDA

CC

GO:0005829

cytosol

The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.

TAS

CC

GO:0005886

plasma membrane

The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

IDA

MF

GO:0000287

magnesium ion binding

Interacting selectively and non-covalently with magnesium (Mg) ions.

IDA|ISS

MF

GO:0003677

DNA binding

Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).

IDA

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0005516

calmodulin binding

Interacting selectively and non-covalently with calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states.

IDA

MF

GO:0005524

ATP binding

Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.

IDA

MF

GO:0008481

sphinganine kinase activity

Catalysis of the reaction: ATP + sphinganine = ADP + sphinganine 1-phosphate.

IDA|TAS

MF

GO:0017050

D-erythro-sphingosine kinase activity

Catalysis of the reaction: sphingosine + ATP = sphingosine 1-phosphate + ADP.

IDA|TAS

MF

GO:0038036

sphingosine-1-phosphate receptor activity

Combining with the sphingolipid sphingosine-1-phosphate (S1P), and transmitting the signal across the membrane by activating an associated G-protein.

IMP

MF

GO:0051721

protein phosphatase 2A binding

Interacting selectively and non-covalently with the enzyme protein phosphatase 2A.

IPI

Domain ID Description

IPR001206

Diacylglycerol kinase, catalytic domain

IPR016064

NAD kinase/diacylglycerol kinase-like domain

IPR017438

Inorganic polyphosphate/ATP-NAD kinase, domain 1

Pathway ID Pathway Term Pathway Source

hsa00600

Sphingolipid metabolism

KEGG

hsa01100

Metabolic pathways

KEGG

hsa04020

Calcium signaling pathway

KEGG

hsa04071

Sphingolipid signaling pathway

KEGG

hsa04072

Phospholipase D signaling pathway

KEGG

hsa04370

VEGF signaling pathway

KEGG

hsa04371

Apelin signaling pathway

KEGG

hsa04666

Fc gamma R-mediated phagocytosis

KEGG

hsa05152

Tuberculosis

KEGG

WP26

Signal Transduction of S1P Receptor

WikiPathways

WP1422

Sphingolipid Metabolism

WikiPathways

h_edg1Pathway

Phospholipids as signalling intermediaries

BioCarta

UMLS CUI UMLS Term

C0009324

Ulcerative Colitis

C0016059

Fibrosis

C0023418

Leukemia

C3463824

Myelodysplastic Syndrome

No tissues found.

No databases found.

Pubmed ID Author Year Title

15598877

Wood et al.

2005

Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

Gene Symbol Entrez ID Uniprot ID Score

LYN

4067

P07948

0.52

MBTPS1

8720

Q14703

0.52

CYLD

1540

Q9NQC7

0.63

DHPS

1725

P49366

0.63

PPM1G

5496

O15355

0.63

RARG

5916

P13631

0.63

DCXR

51181

Q7Z4W1

0.63

CTNND2

1501

Q9UQB3

0.65

FYN

2534

P06241

0.65

BIRC3

330

Q13489

0.68

EEF1A1

1915

P68104

0.68

TRAF6

7189

Q9Y4K3

0.73

CTSB

1508

P07858

0.80

TRAF2

7186

Q12933

0.90

KRAS

3845

P01116

0.00

PLD1

5337

Q13393

0.00

PLD2

5338

O14939

0.00

EP300

2033

Q09472

0.52

FHL2

2274

Q14192

0.73

SPHKAP

80309

Q2M3C7

0.76

RPS6KC1

26750

Q96S38

0.77